Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. Calendar
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on ASTRAZENECA PLC
06/23/21 Guggenheim Biopharma Next Decade Conference
07/02/21 UBS Bus Tour
07/29/21 Interim 2021 Earnings Release
11/12/21 Q3 2021 Earnings Release
Past events on ASTRAZENECA PLC
06/18/21 J.P. Morgan European Healthcare Conference
06/14/21 Bank of America Securities Napa Biopharma Virtual Conference
06/10/21 Wolfe Pipelines Unplugged Meeting
06/09/21 Goldman Sachs Global Healthcare conference
Upcoming sector events for ASTRAZENECA PLC
06/21/21 | 08:00am ROCHE HOLDING AG : European Academy of Neurology Meeting - EPO323
06/21/21 | 10:45am ROCHE HOLDING AG : European Academy of Neurology Meeting - OS3003
06/21/21 | 10:45am ROCHE HOLDING AG : European Academy of Neurology Meeting - Satralizumab in patients with neuromyelitis optica spectrum
06/21/21 | 11:00am ROCHE HOLDING AG : European Academy of Neurology Meeting - OS3005
More events
Past sector events for ASTRAZENECA PLC
06/20/21 | 01:30pm ROCHE HOLDING AG : European Academy of Neurology Meeting - EPO216
06/20/21 | 01:30pm ROCHE HOLDING AG : European Academy of Neurology Meeting - Claims-based algorithm to identify NMOSD patients and relaps
06/20/21 | 09:00am ROCHE HOLDING AG : European Academy of Neurology Meeting - OS2010
06/20/21 | 09:00am ROCHE HOLDING AG : EUROPEAN ACADEMY OF NEUROLOGY MEETING - PHASE II PASADENA PART 1 WEEK 52 RESULTS: Evaluating safety
Annual publications
Annual results201620172018201920202021 (e)
Sales
M $
Released
Forecast
Spread
23 002
23 116
-0,49%
22 465
22 117
1,6%
22 090
22 157
-0,30%
24 384
24 440
-0,23%
26 617
26 378
0,91%

30 966
Operating income
(EBITDA)
M $
Released
Forecast
Spread
7 259
6 503
12%
6 713
6 604
1,7%
7 140
6 767
5,5%
6 686
6 882
-2,8%
8 311
8 087
2,8%

9 951
Operating profit
(EBIT)
M $
Released
Forecast
Spread
6 721
6 648
1,1%
6 855
6 450
6,3%
5 672
5 897
-3,8%
6 436
6 631
-2,9%
7 340
7 417
-1,0%

8 897
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
3 552
2 340
52%
2 227
2 602
-14%
1 993
2 712
-27%
1 548
2 081
-26%
3 916
4 387
-11%

5 218
Net income
M $
Released
Forecast
Spread
3 499
2 413
45%
3 001
2 477
21%
2 155
2 306
-6,6%
1 335
1 895
-30%
3 196
2 930
9,1%

4 588
EPS
$
Released
Forecast
Spread
2,76
1,92
44%
2,37
1,90
25%
1,70
1,79
-4,8%
1,03
1,41
-27%
2,44
2,50
-2,3%

3,20
Announcement Date02/02/201702/02/201802/14/201902/14/202002/11/2021

Quarterly publications
Previous periodNext period
Quarterly results2020 Q12020 Q22020 Q32020 Q42021 Q12021 Q2 (e)
Sales
M $
Released
Forecast
Spread
6 354
5 948
6,8%
6 275
6 279
-0,07%
6 578
6 642
-0,96%
7 410
7 104
4,3%
7 320
6 997
4,6%

7 438
Operating income
(EBITDA)
M $
Released
Forecast
Spread
2 061

1 994

1 972
2 335
-16%
2 284
1 737
31%
2 692
2 904
-7,3%

2 148
Operating profit
(EBIT)
M $
Released
Forecast
Spread
1 854
1 688
9,9%
1 792
1 679
6,7%
1 795
1 811
-0,86%
1 899
1 962
-3,2%
2 524
2 545
-0,81%

1 852
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
935
896
4,4%
961
761
26%
853
904
-5,6%
1 167
1 033
13%
1 608
1 591
1,1%


Net income
M $
Released
Forecast
Spread
780
698
12%
756
630
20%
648
753
-14%
1 012
881
15%
1 561
1 347
16%

651
EPS
$
Released
Forecast
Spread
0,59
0,50
19%
0,58
0,48
21%
0,49
0,56
-13%
0,78
0,67
16%
1,19
1,02
17%

0,57
Announcement Date04/29/202007/30/202011/05/202002/11/202104/30/2021

Financial data source
© 2021 S&P Global Market Intelligence
© 2021 Factset
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise